Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Companies

Novacyt Full Of Eastern Promise, Following Strong H1 Sales

Cervical cancer screening firm Novacyt is aiming to broaden its market penetration in Asia-Pacific by identifying strategic acquisitions. The Anglo-French firm posted strong sales growth of 40% for the first six months of 2017, with APAC representing the group's fastest growing region.

Cancer In Vitro Diagnostics Sales & Earnings

Latest From Companies

Hindsight 20/20: Raymond Cohen

Hindsight 20/20 is a new Q&A feature where medtech industry veterans share their long experience taking diverse businesses – be they start-ups or publicly-listed entities – from strength to strength and navigating through times of crises. This first instalment shines the spotlight on Raymond Cohen, who is currently CEO of venture-backed sacral neuromodulation company Axonics Modulation Technologies, Inc. The advice he gives includes not rushing into clinical studies too soon, try to go big with the fundraising and be very cautious when tackling a complex market like the US, among other things.

Business Strategies Hindsight 2020

Start-Up Spotlight: Rapid Medical, A New Era Of Neurovascular Devices

Israeli company Rapid Medical has developed two controllable neurovascular interventional devices for stroke treatment: the Comaneci mesh device for aneurysm treatment, and the Tigertriever stent retriever for treating ischemic stroke.

Start-up Spotlight StartUps and SMEs

Earnings Winners & Losers, Medtech 'Pure-Plays' BSX, ISRG, BDX, VAR, RMD,

The third of three Winners and Losers features covering the companies that announced sales and earnings results in late July and early August looks at major companies that only market medical devices aside from the orthopedics device makers that were covered in an earlier Winners and Losers feature.

Starts & Stops Commercial

Device Week – Earnings Review, Aug 4, 2017

With earnings season in full swing, Tina Tan and Reed Miller of Medtech Insight review the performances of companies across the orthopedics sector and throw the spotlight on some big medtech pureplays and diversified health care firms.

Sales & Earnings Medical Device

Confirmed: Siemens Aims For H1 2018 IPO for Healthineers

Siemens is planning to spin out its Healthineers business in an IPO slated for the first half of next year, the German conglomerate has confirmed. The move will give the health care business "the required currency and entrepreneurial flexibility" to grow in a fundamentally attractive market, it said. The announcement was made in conjunction with the group's reporting of its third quarter results for fiscal 2017, in which solid diagnostics imaging sales helped to boost the top line for Healthineers.

In Vitro Diagnostics Diagnostic Imaging

Earnings Winners & Losers: Orthopedics Firms, JNJ, NUVA, SNN, SYK, ZBH

With earnings reporting season now in full swing, Medtech Insight highlights which companies have exceeded expectations and which ones continue to see their bottom-line sink. This edition throws the spotlight on some of the notable players in the orthopedics space.

Orthopedics Companies

No Easy Task But Insulet Determined To Fly Solo In Europe

After eight years together, Insulet will be splitting from its exclusive European distributor Ypsomed and take full responsibility for the distribution, sales, marketing, training and support activities of its Omnipod insulin management system in that region. Insulet's president and chief operating officer, Shacey Petrovic told Medtech Insight how the Massachusetts-based company will embark on this next solo chapter.

Diabetic Care Market Access

Abbott’s Devare On Keeping Pace With Viruses And Effective Testing

Timely diagnosis could hold the key to changing the narrative around the emerging hepatitis public health challenge, believes Sushil Devare, Director of Diagnostics Research at Abbott Labs. He explains how Abbott’s HCV Core Antigen test represents an affordable option to nucleic acid tests where the latter is not accessible or unavailable, and also gives Medtech Insight a peek into Abbott’s virus vault under the firm’s global surveillance program.

Infectious Diseases In Vitro Diagnostics

Angle Reels In Positive Clinical Results In Ovarian Cancer Study

Liquid biopsy company Angle plc, has reported positive results for its first large-scale study in Europe and the US using its Parsortix system to detect ovarian cancer. The study evaluated 400 patients for the detection of ovarian cancer in women with a high-risk pelvic mass.

Clinical Trials Cancer
See All